Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumitra Thongprasert

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
ESMO Open|August 30, 2017
<i>ESMO</i> Women for Oncology 2016: a very personal tale of my professional life in AsiaSumitra Thongprasert
Current Medical Research and Opinion|March 10, 2017
Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in ThailandSumitra Thongprasert, Unchalee Permsuwan
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|November 25, 2004
Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancerSumitra Thongprasert, Busyamas Chewaskulyong
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|March 16, 2006
Lung cancer in Maharaj Nakorn Chiang Mai Hospital: comparison of the clinical manifestations between the young and old age groupsAthavudh Deesomchok, Namporn Dechayonbancha, Sumitra Thongprasert
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancerChaiyut Charoentum, Sumitra Thongprasert, Busayamas Chewasakulyong
Value in Health Regional Issues|October 22, 2019
Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in ThailandUnchalee Permsuwan, Sumitra Thongprasert, Buntitabhon Sirichanchuen
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 8, 2003
Docetaxel as second-line chemotherapy for advanced non-small cell lung cancerSumitra Thongprasert, Rattiya Cheewakriangkrai, Sirikul Napapan
Asia-Pacific Journal of Clinical Oncology|February 29, 2012
Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspectiveSumitra Thongprasert, Sirana Tinmanee, Unchalee Permsuwan
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|July 18, 2002
Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancerSumitra Thongprasert, Rattiya Cheewakriangkrai, Juntima Euathrongchit, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|March 8, 2006
Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patientsSumitra Thongprasert, Sukanya Intarapak, Prissana Saengsawang, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
ESMO Open|August 30, 2017
<i>ESMO</i> Women for Oncology 2016: a very personal tale of my professional life in AsiaSumitra Thongprasert
Current Medical Research and Opinion|March 10, 2017
Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in ThailandSumitra Thongprasert, Unchalee Permsuwan
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|November 25, 2004
Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancerSumitra Thongprasert, Busyamas Chewaskulyong
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|March 16, 2006
Lung cancer in Maharaj Nakorn Chiang Mai Hospital: comparison of the clinical manifestations between the young and old age groupsAthavudh Deesomchok, Namporn Dechayonbancha, Sumitra Thongprasert
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancerChaiyut Charoentum, Sumitra Thongprasert, Busayamas Chewasakulyong
Value in Health Regional Issues|October 22, 2019
Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in ThailandUnchalee Permsuwan, Sumitra Thongprasert, Buntitabhon Sirichanchuen
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 8, 2003
Docetaxel as second-line chemotherapy for advanced non-small cell lung cancerSumitra Thongprasert, Rattiya Cheewakriangkrai, Sirikul Napapan
Asia-Pacific Journal of Clinical Oncology|February 29, 2012
Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspectiveSumitra Thongprasert, Sirana Tinmanee, Unchalee Permsuwan
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|July 18, 2002
Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancerSumitra Thongprasert, Rattiya Cheewakriangkrai, Juntima Euathrongchit, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|March 8, 2006
Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patientsSumitra Thongprasert, Sukanya Intarapak, Prissana Saengsawang, et al.
Pageof 5